Transdermal delivery of steroids is gaining popularity for contraception and hormone replacement therapy. This study aimed to test metered spray delivery of a precise dosage of Nestorone (NES) progestogen as a possible transdermal progestogen-only contraceptive.

Objectives of study: 

Six healthy postmenopausal volunteers, not recently using any hormonal therapies, comprised the sample for this study.

Research status: 
Completed
Published articles: 

An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive

Content Owner: 
Research